Data gathered: January 2
AI Stock Analysis - Avidity Biosciences (RNA)
Analysis generated October 7, 2024. Powered by Chat GPT.
Avidity Biosciences is a biopharmaceutical company focused on developing novel therapies to treat rare medical conditions. By leveraging proprietary technologies and strong scientific foundations, Avidity aims to address unmet medical needs through innovative approaches. The company's commitment to scientific advancement and patient outcomes has positioned it as a noteworthy player in the biopharmaceutical sector.
Stock Alerts - Avidity Biosciences (RNA)
 |
Avidity Biosciences | January 2 Price is up by 5.2% in the last 24h. |
|
Avidity Biosciences | December 30 Price is down by -5.1% in the last 24h. |
|
Avidity Biosciences | December 20 Insider Alert: Flanagan W. Michael is continuing selling shares |
|
Avidity Biosciences | December 19 Insider Alert: McCarthy Teresa is selling shares |
Alternative Data for Avidity Biosciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 14 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,000 | Sign up | Sign up | Sign up |
| Employee Rating | 86 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,370 | Sign up | Sign up | Sign up |
| Twitter Followers | 689 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 81 | Sign up | Sign up | Sign up |
| Linkedin Employees | 368 | Sign up | Sign up | Sign up |
About Avidity Biosciences
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics.
| Price | $30.68 |
| Target Price | Sign up |
| Volume | 162,260 |
| Market Cap | $3.47B |
| Year Range | $24.13 - $52.5 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Avidity Biosciences, Inc. (NASDAQ:RNA) Given Consensus Recommendation of “Buy” by AnalystsJanuary 2 - ETF Daily News |
Why Is Avidity Biosciences, Inc. (RNA) Among the Best Multibagger Stocks to Buy Right Now?January 1 - Yahoo Entertainment |
|
|
Avidity Biosciences (NASDAQ:RNA) Trading Down 5.4% – Here’s What HappenedDecember 30 - ETF Daily News |
|
Head to Head Comparison: Avidity Biosciences (NASDAQ:RNA) versus NeuroSense Therapeutics (NASDAQ:NRSN)December 25 - ETF Daily News |
|
Franklin Resources Inc. Buys 50,908 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)December 25 - ETF Daily News |
|
Tidal Investments LLC Makes New Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)December 24 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 2.3M | 23M | -21M | -80M | 0 | 0.000 |
| Q2 '24 | 2M | 21M | -19M | -71M | -82M | -0.650 |
| Q1 '24 | 3.5M | 14M | -10M | -69M | -77M | -0.790 |
| Q4 '23 | 2.2M | 16M | -14M | -60M | -66M | -0.790 |
| Q3 '23 | 2.8M | 14M | -11M | -52M | -58M | -0.710 |
Insider Transactions View All
| McCarthy Teresa filed to sell 82,867 shares at $32.7. December 19 '24 |
| Boyce Sarah filed to sell 265,308 shares at $32.7. December 19 '24 |
| MacLean Michael F filed to sell 82,942 shares at $32.7. December 19 '24 |
| Flanagan W. Michael filed to sell 72,647 shares at $32.7. December 19 '24 |
| McCarthy Teresa filed to sell 94,018 shares at $33.3. December 18 '24 |
Similar companies
Read more about Avidity Biosciences (RNA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Avidity Biosciences?
The Market Cap of Avidity Biosciences is $3.47B.
What is the current stock price of Avidity Biosciences?
Currently, the price of one share of Avidity Biosciences stock is $30.68.
How can I analyze the RNA stock price chart for investment decisions?
The RNA stock price chart above provides a comprehensive visual representation of Avidity Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Avidity Biosciences shares. Our platform offers an up-to-date RNA stock price chart, along with technical data analysis and alternative data insights.
Does RNA offer dividends to its shareholders?
As of our latest update, Avidity Biosciences (RNA) does not offer dividends to its shareholders. Investors interested in Avidity Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Avidity Biosciences?
Some of the similar stocks of Avidity Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.